2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52) – a novel type of 5-lipoxygenase inhibitor with favourable molecular pharmacology and efficacy in vivo

Por Greiner, C, Hörnig, C, Rossi, A, Pergola, C, Zettl, H, Schubert-Zsilavecz, M, Steinhilber, D, Sautebin, L, Werz, O
Publicado em 2011

Kernel learning for ligand-based virtual screening: discovery of a new PPARγ agonist

Por Rupp, Matthias, Schroeter, T, Steri, R, Proschak, Ewgenij, Hansen, K, Zettl, H, Rau, O, Schubert-Zsilavecz, M, Müller, K-R, Schneider, Gisbert
Publicado em 2010